Annual reports

From collaborations delivering faster diagnoses for children with epilepsy to partnerships tackling the worldwide shortage of viral vectors, here are some of the highlights from 2024/25.

From advancing organoid science to pioneering a new approach for delivering life-changing gene therapies, here are some of the highlights from 2023/24.

From solving the rise in childhood hepatitis to using CRISPR/Cas9 technology to engineer donor T cells to try to treat seriously ill children with resistant leukaemia, here are some of the highlights from 2022/23.

From a global collaboration to develop new treatments for paediatric diseases to new insight into when CAR-T is effective against childhood leukaemia, here are some of the highlights from 2021.